FIVE PRIME THERAPEUTICS, INC. 3/A SEC Filings

Filed On	Filing
12 Jun 2019	Form 3/A: Nicholson Garry A, Director No securities owned
02 May 2019	Form 3/A: Irving Bryan, EVP, Chief Scientific Officer No securities owned
02 May 2019	Form 3/A: Collins Helen Louise, SVP and Chief Medical Officer
02 May 2019	Form 3/A: Smith David V, Executive Vice President & CFO No securities owned
28 Feb 2018	Form 3/A: Collins Helen Louise, SVP and Chief Medical Officer Holds 25,156.25 shares of Common Stock

Comments